Futura Medical (GB:FUM) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Futura Medical PLC, a company trading on the AIM market under the ticker FUM and specializing in innovative sexual health products, announced its total issued share capital stands at 302,403,003 Ordinary Shares, with the same number of voting rights as no shares are held in treasury. The company highlighted its lead product Eroxon, a unique topical gel for treating Erectile Dysfunction that works in ten minutes and is available over the counter. They also boast of strategic distribution partnerships across major consumer markets, including the US and Europe.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.